Nutritional risk and metabolic syndrome in Korean type 2 diabetes mellitus

Wha Young Kim; Jung Eun Kim; Young Joo Choi; Kap Bum Huh
March 2008
Asia Pacific Journal of Clinical Nutrition;2008 Supplement 1, Vol. 17, p47
Academic Journal
The prevalence of diabetes mellitus (DM) and the metabolic syndrome (MetS) are rapidly increasing in Asia including Korea. In 2005, the Third Korea National Health and Nutrition examination survey (KNHANES III) reported that the prevalence of DM and MetS in adults was estimated to be 8.7% and 32.6%, respectively. In our study of 688 type 2 DM patients, MetS prevalence was 46.9 % for males, and 65.1% for females. Patients with T2DM and MetS showed significantly higher insulin resistance than T2DM without MetS, confirming that insulin resistance is an important feature of MetS in T2DM patients. Patients with T2DM and MetS showed higher BMI, waist circumference, blood triglycerides, atherogenic index, C-reactive protein and lower HDL-cholesterol. In recent years, concerns with regard to the association of diet with MetS have grown. In our study with non-DM elderly people, higher % energy from carbohydrate, and lower intakes of antioxidant vitamins were considered to be associated with the risk of MetS. Patients with T2DM and MetS showed significant positive correlations between intakes of energy, carbohydrate, protein and lipids with BMI, weight, as well as waist circumference. These associations were not found in patients with T2DM without MetS. Nutritional risk factors for MetS among middle-aged T2DM subjects would be excessive carbohydrate intake with low intakes of fat, protein, vitamins, and minerals.


Related Articles

  • Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle. Hayden, Melvin R.; Tyagi, Suresh C. // Nutrition & Metabolism;2004, Vol. 1, p10 

    Background: The topical role of uric acid and its relation to cardiovascular disease, renal disease, and hypertension is rapidly evolving. Its important role both historically and currently in the clinical clustering phenomenon of the metabolic syndrome (MS), type 2 diabetes mellitus (T2DM),...

  • Advancing drug therapy of the metabolic syndrome. Grundy, Scott M // Nature Reviews Drug Discovery;May2009, Vol. 8 Issue 5, p341 

    The metabolic syndrome — a group of factors that raise the risk of cardiovascular disease and type 2 diabetes — is increasingly common. How might the challenges of developing improved therapies to normalize these risk factors be approached?

  • Shorts. Klotter, Jule // Townsend Letter;May2007, Issue 286, p26 

    The article offers news briefs related to medicine in the U.S. Family doctors who care for 90% of the nation's diabetics are experiencing a difficult adjustment on medications and monitoring patients with several diseases. Metabolic syndrome is labeled for a group of measurements associated with...

  • Abdominal Obesity Determines the Cardiovascular Risk in Type 2 DM: A Cross-Sectional Study in Spain. Albarran, Olga Gonzalez; Lahera, Marcos; Segura, Julian; Ruilope, Luis M.; Aragón, Carmen; Segura, Raúl; Sancho, José M. // Diabetes;Jun2007 Supplement 1, Vol. 56, pA595 

    Obesity and Metabolic syndrome (MS) have been associated with a high incidence of cardiovascular events. The aims of the present work were 1) to evaluate the prevalence of abdominal obesity (AO) and MS in a cohort of patients with type 2 DM. 2) to assess blood pressure (BP) control rates in...

  • Cardiovascular risk in type 1 diabetes mellitus. Ines Ben Hadj Slama Slim // Indian Journal of Endocrinology & Metabolism;2013 Supplement, Vol. 17 Issue S1, pS7 

    Commonly cardiovascular risk (CVR) is linked to type 2 diabetes mellitus as this type is known to be part of the metabolic syndrome, which includes other cardiovascular factors such as hypertension, dyslipidemia. Inversely, CVR of type 1 diabetes mellitus (T1 DM) is currently being debated apart...

  • Childhood Metabolic Syndrome. WEISS, RAM // Diabetes Care;May2011 Supplement 2, Vol. 34, pS171 

    The article offers information on childhood metabolic syndrome. Also called syndrome X, this condition describes a cluster of cardiovascular risk factors which predict the development of cardiovascular disease and type 2 diabetes. Several components in the definition of metabolic syndrome in...

  • Does the Metabolic Syndrome Exist? Grundy, Scott M. // Diabetes Care;Jul2006, Vol. 29 Issue 7, p1689 

    The article examines whether the well-established clustering of metabolic risk factors underlying both cardiovascular disease and type 2 diabetes deserve to be called a syndrome and, even if the metabolic syndrome can be accepted as a concept, whether the concept has matured enough to be...

  • Impact of Insulin Resistance on Risk of Type 2 Diabetes and Cardiovascular Disease in People With Metabolic Syndrome. Meigs, James B.; Rutter, Martin K.; Sullivan, Lisa M.; Fox, Caroline S.; D'Agostino Sr., Ralph B.; Wilson, Peter W. F. // Diabetes Care;May2007, Vol. 30 Issue 5, p1219 

    OBJECTIVE -- Metabolic syndrome increases the risk for type 2 diabetes and cardiovascular disease (CVD) and may be associated with insulin resistance. RESEARCH DESIGN AND METHODS -- We tested the hypothesis that the metabolic syndrome confers risk with or without concomitant insulin resistance...

  • Impact of type 2 diabetes and the metabolic syndrome on myocardial structure and microvasculature of men with coronary artery disease.  // Cardiovascular Diabetology;2011, Vol. 10 Issue 1, p80 

    The article informs on a research that analyzes the effect of type two 2 diabetes and metabolic syndrome on myocardial structure and microvasculature of patients with coronary artery disease. It is mentioned that type two diabetes and metabolic syndrome are often the causative factors for...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics